In Brief: Influenza vaccine
Executive Summary
Influenza vaccine: FDA's Vaccines and Related Biologics Advisory Committee will meet March 7 to finalize influenza virus vaccine formulation for 1996-97 season. The advisory committee in January selected one of three strains that should be included in the vaccine for the upcoming flu season, but deferred a decision on the other two strains until FDA gathered more information. The meeting begins at 3 p.m. at Bldg. 29 on the NIH campus in Bethesda, Md...